Safety of the maternal–infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study
Rhoda Sperling(MDS Associates (United States)), Jean-François Delfraissy(Agence Nationale de Recherches sur le Sida et les Hépatites Virales), Bethann E. Cunningham(Frontier Science & Technology Research Foundation, Inc.), Mary Culnane(National Institute of Allergy and Infectious Diseases), William T. Shearer(Baylor College of Medicine), David E. Shapiro(Intercept Pharmaceuticals (United States)), Robert W. Coombs(University of Namur), Clemente Díaz(University of Puerto Rico System), Eleanor Jiménez(University of Miami), Russell B. Van Dyke(Tulane University), Paula Britto(Cancer Research And Biostatistics), George McSherry(Rutgers New Jersey Medical School), Gwendolyn B. Scott, Duane D. Harrison(Wayne State University)
Cited by 166
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k